These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23458217)

  • 21. StatBite: Percent change in DCIS, invasive breast cancer, and mammography.
    J Natl Cancer Inst; 2011 Mar; 103(6):457. PubMed ID: 21393608
    [No Abstract]   [Full Text] [Related]  

  • 22. Pathological secretion of the breast.
    Muller JW; In der Maur GA
    Diagn Imaging; 1982; 51(2):62-8. PubMed ID: 6280940
    [No Abstract]   [Full Text] [Related]  

  • 23. Ductal Carcinoma In Situ and Breast Cancer Overdiagnosis.
    Jatoi I
    J Clin Oncol; 2022 May; 40(14):1595. PubMed ID: 35245098
    [No Abstract]   [Full Text] [Related]  

  • 24. The present status of mammary thermography.
    Haberman JD
    CA Cancer J Clin; 1968; 18(6):315-21. PubMed ID: 4321971
    [No Abstract]   [Full Text] [Related]  

  • 25. Screening mammography starting at age 40: Still relevant.
    Ghosh K; Wahner-Roedler D; Brandt K
    Cleve Clin J Med; 2015 May; 82(5):276-9. PubMed ID: 25973872
    [No Abstract]   [Full Text] [Related]  

  • 26. Team approach tthe study of diseases of the breast.
    Egan RL; Ellis JT; Powell RW
    Cancer; 1969 Apr; 23(4):847-54. PubMed ID: 4304779
    [No Abstract]   [Full Text] [Related]  

  • 27. Nonenhancing breast malignancies on MRI: sonographic and pathologic correlation.
    Ghai S; Muradali D; Bukhanov K; Kulkarni S
    AJR Am J Roentgenol; 2005 Aug; 185(2):481-7. PubMed ID: 16037524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of needle localization in the diagnosis of occult breast cancer.
    Amin EA; Meyer JE
    J Ky Med Assoc; 1988 May; 86(5):229-34. PubMed ID: 2838558
    [No Abstract]   [Full Text] [Related]  

  • 29. [Discharges by the mamilla without palpable tumor. 500 cases observed at the Curie institution. Anatomo-pathological study and therapeutic indications].
    Pilleron JP; Durand JC; Labeta C
    J Chir (Paris); 1970 Oct; 100(4):295-314. PubMed ID: 4321592
    [No Abstract]   [Full Text] [Related]  

  • 30. Preoperative MRI of pure intraductal breast carcinoma--a valuable adjunct to mammography in assessing cancer extent.
    Santamaría G; Velasco M; Farrús B; Zanón G; Fernández PL
    Breast; 2008 Apr; 17(2):186-94. PubMed ID: 17964786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis.
    van Ravesteyn NT; Stout NK; Schechter CB; Heijnsdijk EA; Alagoz O; Trentham-Dietz A; Mandelblatt JS; de Koning HJ
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25948872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Combined clinical and mammographic mass screening in breast cancer].
    Lányi M; László G; Farkas M
    Fortschr Geb Rontgenstr Nuklearmed; 1970 Jan; 11(1):18-26. PubMed ID: 4324683
    [No Abstract]   [Full Text] [Related]  

  • 33. Analysis of clinically occult and mammographically occult breast tumors.
    Feig SA; Shaber GS; Patchefsky A; Schwartz GF; Edeiken J; Libshitz HI; Nerlinger R; Curley RF; Wallace JD
    AJR Am J Roentgenol; 1977 Mar; 128(3):403-8. PubMed ID: 190908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overdiagnosis of breast cancer in Norway: what have the authors adjusted for?
    Zahl PH; Suhrke P; Jørgensen KJ
    Int J Cancer; 2013 Dec; 133(11):2754-5. PubMed ID: 23650050
    [No Abstract]   [Full Text] [Related]  

  • 35. The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.
    Kim JS; Lee SM; Cha ES
    Acta Radiol; 2014 Jul; 55(6):668-75. PubMed ID: 24043881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer screening.
    Milbrath JR; Moskowitz M; Bauermeister D
    Crit Rev Diagn Imaging; 1981; 16(3):181-218. PubMed ID: 6268356
    [No Abstract]   [Full Text] [Related]  

  • 37. Reduction in late-stage breast cancer incidence in the mammography era: Implications for overdiagnosis of invasive cancer.
    Helvie MA; Chang JT; Hendrick RE; Banerjee M
    Cancer; 2014 Sep; 120(17):2649-56. PubMed ID: 24840597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preventing invasive breast cancer: another benefit from mammographic screening.
    Cady B; Chung MA
    Cancer; 2011 Jul; 117(14):3064-8. PubMed ID: 21246518
    [No Abstract]   [Full Text] [Related]  

  • 39. Diagnosis of mammary cancer.
    Donegan WL
    Major Probl Clin Surg; 1967; 5():34-69. PubMed ID: 4351550
    [No Abstract]   [Full Text] [Related]  

  • 40. [Mammography in breast cancer].
    Zal'tsman IN
    Med Radiol (Mosk); 1972 Jul; 17(7):23-8. PubMed ID: 4351234
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.